Terumo Corporation
A single plant registered with the FDA to make drugs for the US market. Below is where it is and the drugs whose FDA labels list this site as performing a manufacturing step — so if this plant has a problem, these are the products that could be affected.
- Country
- Japan
- Registered address
- 818, Misonodaira, Fujinomiya-City, Shizuoka 418-0004, Japan (JPN)
- Operations here
- analysislabelmanufacturepacksterilize
- FDA identifiers
- FEI 3002808337 · DUNS 695214015
FDA inspection history
Outcomes of closed FDA inspections at this site (drug and biologic program areas).
- VAIDrug Quality Assurance2017-02-07
- VAIDrug Quality Assurance2014-03-20
- VAIDrug Quality Assurance2011-09-16
Drugs this plant is listed as making
5 distinct drugs across 7 products name this site in their FDA label.
- Anhydrous Citric Acid, Trisodium Citrate Dihydrate, Sodium Phosphate, Monobasic, Monohydrate, Dextrose Monohydrate, and AdenineTerumo Corporation
- Anticoagulant Citrate Phosphate Dextrose (CPD) and AS-5 Red Cell PreservativeTerumo Corporation
- Dextrose Monohydrate, Trisodium Citrate Dihydrate, Anhydrous Citric Acid, Sodium Phosphate, Monobasic, Unspecified Form, Anhydrous Dextrose, Sodium Chloride, Mannitol, and AdenineTerumo Corporation
- dextrose monohydrate, trisodium citrate dihydrate, anhydrous citric acid, sodium phosphate, monobasic, unspecified form, sodium chloride, mannitol, and adenineTerumo Corporation
Sources:the establishment's name, address, and country from FDA's Drug Establishments Current Registration Site (DECRS); the drug-to-facility links from DailyMed SPL drug labels, matched by the facility's DUNS number; inspection outcomes from the FDA Data Dashboard, matched by FEI; shortage status from FDA's drug shortage database. More on how this is built. Educational only.